ParkinsonFranceV1, PascalFrancis, Curation, bibRecord, 001885

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study

Identifieur interne : 001885 ( PascalFrancis/Curation ); précédent : 001884; suivant : 001886

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study

Auteurs : I. Litvan [États-Unis] ; G. Campbell [États-Unis] ; C. A. Mangone [États-Unis] ; M. Verny [France] ; A. Mckee [États-Unis] ; K. Ray Chaudhuri [Royaume-Uni] ; K. Jellinger [Autriche] ; R. K. B. Pearce [Royaume-Uni] ; L. D'Olhaberriague [États-Unis]

Source :

Brain [ 0006-8950 ] ; 1997.

RBID : Pascal:97-0171624

Descripteurs français

Pascal (Inist)
- Ophtalmoplégie supranucléaire, Progressif, Anatomopathologie, Classification, Diagnostic différentiel, Homme, Analyse statistique.
Wicri :
- topic : Classification, Homme.

English descriptors

KwdEn :
- Classification, Differential diagnostic, Human, Pathology, Progressive, Statistical analysis, Supranuclear ophthalmoplegia.

Abstract

The difficulty in differentiating progressive supranuclear palsy (PSP, also called Steele-Richardson-Olszewski syndrome) from other related disorders was the incentive for a study to determine the clinical features that best distinguish PSP. Logistic regression and classification and regression tree analysis (CART) were used to analyse data obtained at the first visit from a sample of 83 patients with a clinical history of parkinsonism or dementia confirmed neuropathologically including PSP (n = 24), corticobasal degeneration (n = 11), Parkinson's disease (PD, n = 11), diffuse Lewy body disease (n = 14), Pick's disease (n = 8) and multiple system atrophy (MSA, n = 15). Supranuclear vertical gaze palsy, moderate or severe postural instability and falls during the first year after onset of symptoms classified the sample with 9% error using logistic regression analysis. The CART identified similar features and was also helpful in identifying particular attributes that separate PSP from each of the other disorders. Unstable gait, absence of tremor-dominant disease and absence of response to levodopa differentiated PSP from PD. Supranuclear vertical gaze palsy, gait instability and the absence of delusions distinguished PSP from diffuse Lewy body disease. Supranuclear vertical gaze palsy and increased age at symptom-onset distinguished PSP from MSA. Gait abnormality severe upward gaze palsy, bilateral bradykinesia and absence of alien limb syndrome separated PSP from corticobasal degeneration. Postural instability successfully classified PSP from Pick's disease. The present study may help to minimize the difficulties neurologists experience when attempting to classify these disorders at early stages.

A01	`01`	`1`		`@0 0006-8950`
A03		`1`		`@0 Brain`
A05				`@2 120`
A06				`@3 p.1`
A08	`01`	`1`	`ENG`	`@1 Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study`
A11	`01`	`1`		`@1 LITVAN (I.)`
A11	`02`	`1`		`@1 CAMPBELL (G.)`
A11	`03`	`1`		`@1 MANGONE (C. A.)`
A11	`04`	`1`		`@1 VERNY (M.)`
A11	`05`	`1`		`@1 MCKEE (A.)`
A11	`06`	`1`		`@1 RAY CHAUDHURI (K.)`
A11	`07`	`1`		`@1 JELLINGER (K.)`
A11	`08`	`1`		`@1 PEARCE (R. K. B.)`
A11	`09`	`1`		`@1 D'OLHABERRIAGUE (L.)`
A14	`01`			`@1 Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health @2 Bethesda @3 USA @Z 1 aut. @Z 3 aut. @Z 9 aut.`
A14	`02`			`@1 Analytical Biometrics Section, Biometry and Field Studies Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health @2 Bethesda @3 USA @Z 2 aut.`
A14	`03`			`@1 Raymond Escourolle Neuropathology Laboratory, Hôpital de la Salpêtrière @2 Paris @3 FRA @Z 4 aut.`
A14	`04`			`@1 Department of Neuropathology, Massachusetts General Hospital @2 Boston @3 USA @Z 5 aut.`
A14	`05`			`@1 Department of Neurology Institute of Psychiatry @2 London @3 GBR @Z 6 aut.`
A14	`06`			`@1 Ludwig Boltzmann Institute of Clinical Neurobiology @2 Vienna @3 AUT @Z 7 aut.`
A14	`07`			`@1 Parkinson's Disease Society Brain Tissue Bank, Institute of Neurology @2 London @3 GBR @Z 8 aut.`
A20				`@1 65-74`
A21				`@1 1997`
A23	`01`			`@0 ENG`
A43	`01`			`@1 INIST @2 998 @5 354000063119560060`
A44				`@0 0000 @1 © 1997 INIST-CNRS. All rights reserved.`
A45				`@0 2 p.`
A47	`01`	`1`		`@0 97-0171624`
A60				`@1 P`
A61				`@0 A`
A64	`01`	`1`		`@0 Brain`
A66	`01`			`@0 GBR`
C01	`01`		`ENG`	@0 The difficulty in differentiating progressive supranuclear palsy (PSP, also called Steele-Richardson-Olszewski syndrome) from other related disorders was the incentive for a study to determine the clinical features that best distinguish PSP. Logistic regression and classification and regression tree analysis (CART) were used to analyse data obtained at the first visit from a sample of 83 patients with a clinical history of parkinsonism or dementia confirmed neuropathologically including PSP (n = 24), corticobasal degeneration (n = 11), Parkinson's disease (PD, n = 11), diffuse Lewy body disease (n = 14), Pick's disease (n = 8) and multiple system atrophy (MSA, n = 15). Supranuclear vertical gaze palsy, moderate or severe postural instability and falls during the first year after onset of symptoms classified the sample with 9% error using logistic regression analysis. The CART identified similar features and was also helpful in identifying particular attributes that separate PSP from each of the other disorders. Unstable gait, absence of tremor-dominant disease and absence of response to levodopa differentiated PSP from PD. Supranuclear vertical gaze palsy, gait instability and the absence of delusions distinguished PSP from diffuse Lewy body disease. Supranuclear vertical gaze palsy and increased age at symptom-onset distinguished PSP from MSA. Gait abnormality severe upward gaze palsy, bilateral bradykinesia and absence of alien limb syndrome separated PSP from corticobasal degeneration. Postural instability successfully classified PSP from Pick's disease. The present study may help to minimize the difficulties neurologists experience when attempting to classify these disorders at early stages.
C02	`01`	`X`		`@0 002B17G`
C03	`01`	`X`	`FRE`	`@0 Ophtalmoplégie supranucléaire @5 01`
C03	`01`	`X`	`ENG`	`@0 Supranuclear ophthalmoplegia @5 01`
C03	`01`	`X`	`SPA`	`@0 Oftalmoplejía supranuclear @5 01`
C03	`02`	`X`	`FRE`	`@0 Progressif @5 02`
C03	`02`	`X`	`ENG`	`@0 Progressive @5 02`
C03	`02`	`X`	`SPA`	`@0 Progresivo @5 02`
C03	`03`	`X`	`FRE`	`@0 Anatomopathologie @5 04`
C03	`03`	`X`	`ENG`	`@0 Pathology @5 04`
C03	`03`	`X`	`SPA`	`@0 Anatomía patológica @5 04`
C03	`04`	`X`	`FRE`	`@0 Classification @5 16`
C03	`04`	`X`	`ENG`	`@0 Classification @5 16`
C03	`04`	`X`	`GER`	`@0 Klassifizierung @5 16`
C03	`04`	`X`	`SPA`	`@0 Clasificación @5 16`
C03	`05`	`X`	`FRE`	`@0 Diagnostic différentiel @5 17`
C03	`05`	`X`	`ENG`	`@0 Differential diagnostic @5 17`
C03	`05`	`X`	`SPA`	`@0 Diagnóstico diferencial @5 17`
C03	`06`	`X`	`FRE`	`@0 Homme @5 20`
C03	`06`	`X`	`ENG`	`@0 Human @5 20`
C03	`06`	`X`	`SPA`	`@0 Hombre @5 20`
C03	`07`	`X`	`FRE`	`@0 Analyse statistique @5 23`
C03	`07`	`X`	`ENG`	`@0 Statistical analysis @5 23`
C03	`07`	`X`	`GER`	`@0 Statistische Analyse @5 23`
C03	`07`	`X`	`SPA`	`@0 Análisis estadístico @5 23`
C07	`01`	`X`	`FRE`	`@0 Oeil pathologie @5 37`
C07	`01`	`X`	`ENG`	`@0 Eye disease @5 37`
C07	`01`	`X`	`SPA`	`@0 Ojo patología @5 37`
C07	`02`	`X`	`FRE`	`@0 Oculomotricité syndrome @5 38`
C07	`02`	`X`	`ENG`	`@0 Oculomotor syndrome @5 38`
C07	`02`	`X`	`SPA`	`@0 Oculomotricidad síndrome @5 38`
C07	`03`	`X`	`FRE`	`@0 Système nerveux pathologie @5 39`
C07	`03`	`X`	`ENG`	`@0 Nervous system diseases @5 39`
C07	`03`	`X`	`SPA`	`@0 Sistema nervioso patología @5 39`
C07	`04`	`X`	`FRE`	`@0 Système nerveux central pathologie @5 40`
C07	`04`	`X`	`ENG`	`@0 Central nervous system disease @5 40`
C07	`04`	`X`	`SPA`	`@0 Sistema nervosio central patología @5 40`
C07	`05`	`X`	`FRE`	`@0 Tronc cérébral syndrome @5 41`
C07	`05`	`X`	`ENG`	`@0 Brain stem syndrome @5 41`
C07	`05`	`X`	`SPA`	`@0 Tallo encefalico sindrome @5 41`
C07	`06`	`X`	`FRE`	`@0 Encéphale pathologie @5 42`
C07	`06`	`X`	`ENG`	`@0 Cerebral disorder @5 42`
C07	`06`	`X`	`SPA`	`@0 Encéfalo patología @5 42`
C07	`07`	`X`	`FRE`	`@0 Maladie dégénérative @5 43`
C07	`07`	`X`	`ENG`	`@0 Degenerative disease @5 43`
C07	`07`	`X`	`SPA`	`@0 Enfermedad degenerativa @5 43`
N21				`@1 083`

Links toward previous steps (curation, corpus...)

to stream PascalFrancis, to step Corpus: Pour aller vers cette notice dans l'étape Curation :001761

Links to Exploration step

Pascal:97-0171624

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en" level="a">Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study</title>
<author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I." last="Litvan">I. Litvan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Campbell, G" sort="Campbell, G" uniqKey="Campbell G" first="G." last="Campbell">G. Campbell</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Analytical Biometrics Section, Biometry and Field Studies Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mangone, C A" sort="Mangone, C A" uniqKey="Mangone C" first="C. A." last="Mangone">C. A. Mangone</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Verny, M" sort="Verny, M" uniqKey="Verny M" first="M." last="Verny">M. Verny</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Raymond Escourolle Neuropathology Laboratory, Hôpital de la Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Mckee, A" sort="Mckee, A" uniqKey="Mckee A" first="A." last="Mckee">A. Mckee</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neuropathology, Massachusetts General Hospital</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Ray Chaudhuri, K" sort="Ray Chaudhuri, K" uniqKey="Ray Chaudhuri K" first="K." last="Ray Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Neurology Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K." last="Jellinger">K. Jellinger</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Ludwig Boltzmann Institute of Clinical Neurobiology</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Pearce, R K B" sort="Pearce, R K B" uniqKey="Pearce R" first="R. K. B." last="Pearce">R. K. B. Pearce</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Parkinson's Disease Society Brain Tissue Bank, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="D Olhaberriague, L" sort="D Olhaberriague, L" uniqKey="D Olhaberriague L" first="L." last="D'Olhaberriague">L. D'Olhaberriague</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">INIST</idno>
<idno type="inist">97-0171624</idno>
<date when="1997">1997</date>
<idno type="stanalyst">PASCAL 97-0171624 INIST</idno>
<idno type="RBID">Pascal:97-0171624</idno>
<idno type="wicri:Area/PascalFrancis/Corpus">001761</idno>
<idno type="wicri:Area/PascalFrancis/Curation">001885</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a">Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study</title>
<author><name sortKey="Litvan, I" sort="Litvan, I" uniqKey="Litvan I" first="I." last="Litvan">I. Litvan</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Campbell, G" sort="Campbell, G" uniqKey="Campbell G" first="G." last="Campbell">G. Campbell</name>
<affiliation wicri:level="1"><inist:fA14 i1="02"><s1>Analytical Biometrics Section, Biometry and Field Studies Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Mangone, C A" sort="Mangone, C A" uniqKey="Mangone C" first="C. A." last="Mangone">C. A. Mangone</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Verny, M" sort="Verny, M" uniqKey="Verny M" first="M." last="Verny">M. Verny</name>
<affiliation wicri:level="1"><inist:fA14 i1="03"><s1>Raymond Escourolle Neuropathology Laboratory, Hôpital de la Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</inist:fA14>
<country>France</country>
</affiliation>
</author>
<author><name sortKey="Mckee, A" sort="Mckee, A" uniqKey="Mckee A" first="A." last="Mckee">A. Mckee</name>
<affiliation wicri:level="1"><inist:fA14 i1="04"><s1>Department of Neuropathology, Massachusetts General Hospital</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
<author><name sortKey="Ray Chaudhuri, K" sort="Ray Chaudhuri, K" uniqKey="Ray Chaudhuri K" first="K." last="Ray Chaudhuri">K. Ray Chaudhuri</name>
<affiliation wicri:level="1"><inist:fA14 i1="05"><s1>Department of Neurology Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="Jellinger, K" sort="Jellinger, K" uniqKey="Jellinger K" first="K." last="Jellinger">K. Jellinger</name>
<affiliation wicri:level="1"><inist:fA14 i1="06"><s1>Ludwig Boltzmann Institute of Clinical Neurobiology</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</inist:fA14>
<country>Autriche</country>
</affiliation>
</author>
<author><name sortKey="Pearce, R K B" sort="Pearce, R K B" uniqKey="Pearce R" first="R. K. B." last="Pearce">R. K. B. Pearce</name>
<affiliation wicri:level="1"><inist:fA14 i1="07"><s1>Parkinson's Disease Society Brain Tissue Bank, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</inist:fA14>
<country>Royaume-Uni</country>
</affiliation>
</author>
<author><name sortKey="D Olhaberriague, L" sort="D Olhaberriague, L" uniqKey="D Olhaberriague L" first="L." last="D'Olhaberriague">L. D'Olhaberriague</name>
<affiliation wicri:level="1"><inist:fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</inist:fA14>
<country>États-Unis</country>
</affiliation>
</author>
</analytic>
<series><title level="j" type="main">Brain</title>
<title level="j" type="abbreviated">Brain</title>
<idno type="ISSN">0006-8950</idno>
<imprint><date when="1997">1997</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
<seriesStmt><title level="j" type="main">Brain</title>
<title level="j" type="abbreviated">Brain</title>
<idno type="ISSN">0006-8950</idno>
</seriesStmt>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Classification</term>
<term>Differential diagnostic</term>
<term>Human</term>
<term>Pathology</term>
<term>Progressive</term>
<term>Statistical analysis</term>
<term>Supranuclear ophthalmoplegia</term>
</keywords>
<keywords scheme="Pascal" xml:lang="fr"><term>Ophtalmoplégie supranucléaire</term>
<term>Progressif</term>
<term>Anatomopathologie</term>
<term>Classification</term>
<term>Diagnostic différentiel</term>
<term>Homme</term>
<term>Analyse statistique</term>
</keywords>
<keywords scheme="Wicri" type="topic" xml:lang="fr"><term>Classification</term>
<term>Homme</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The difficulty in differentiating progressive supranuclear palsy (PSP, also called Steele-Richardson-Olszewski syndrome) from other related disorders was the incentive for a study to determine the clinical features that best distinguish PSP. Logistic regression and classification and regression tree analysis (CART) were used to analyse data obtained at the first visit from a sample of 83 patients with a clinical history of parkinsonism or dementia confirmed neuropathologically including PSP (n = 24), corticobasal degeneration (n = 11), Parkinson's disease (PD, n = 11), diffuse Lewy body disease (n = 14), Pick's disease (n = 8) and multiple system atrophy (MSA, n = 15). Supranuclear vertical gaze palsy, moderate or severe postural instability and falls during the first year after onset of symptoms classified the sample with 9% error using logistic regression analysis. The CART identified similar features and was also helpful in identifying particular attributes that separate PSP from each of the other disorders. Unstable gait, absence of tremor-dominant disease and absence of response to levodopa differentiated PSP from PD. Supranuclear vertical gaze palsy, gait instability and the absence of delusions distinguished PSP from diffuse Lewy body disease. Supranuclear vertical gaze palsy and increased age at symptom-onset distinguished PSP from MSA. Gait abnormality severe upward gaze palsy, bilateral bradykinesia and absence of alien limb syndrome separated PSP from corticobasal degeneration. Postural instability successfully classified PSP from Pick's disease. The present study may help to minimize the difficulties neurologists experience when attempting to classify these disorders at early stages.</div>
</front>
</TEI>
<inist><standard h6="B"><pA><fA01 i1="01" i2="1"><s0>0006-8950</s0>
</fA01>
<fA03 i2="1"><s0>Brain</s0>
</fA03>
<fA05><s2>120</s2>
</fA05>
<fA06><s3>p.1</s3>
</fA06>
<fA08 i1="01" i2="1" l="ENG"><s1>Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study</s1>
</fA08>
<fA11 i1="01" i2="1"><s1>LITVAN (I.)</s1>
</fA11>
<fA11 i1="02" i2="1"><s1>CAMPBELL (G.)</s1>
</fA11>
<fA11 i1="03" i2="1"><s1>MANGONE (C. A.)</s1>
</fA11>
<fA11 i1="04" i2="1"><s1>VERNY (M.)</s1>
</fA11>
<fA11 i1="05" i2="1"><s1>MCKEE (A.)</s1>
</fA11>
<fA11 i1="06" i2="1"><s1>RAY CHAUDHURI (K.)</s1>
</fA11>
<fA11 i1="07" i2="1"><s1>JELLINGER (K.)</s1>
</fA11>
<fA11 i1="08" i2="1"><s1>PEARCE (R. K. B.)</s1>
</fA11>
<fA11 i1="09" i2="1"><s1>D'OLHABERRIAGUE (L.)</s1>
</fA11>
<fA14 i1="01"><s1>Neuroepidemiology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>1 aut.</sZ>
<sZ>3 aut.</sZ>
<sZ>9 aut.</sZ>
</fA14>
<fA14 i1="02"><s1>Analytical Biometrics Section, Biometry and Field Studies Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health</s1>
<s2>Bethesda</s2>
<s3>USA</s3>
<sZ>2 aut.</sZ>
</fA14>
<fA14 i1="03"><s1>Raymond Escourolle Neuropathology Laboratory, Hôpital de la Salpêtrière</s1>
<s2>Paris</s2>
<s3>FRA</s3>
<sZ>4 aut.</sZ>
</fA14>
<fA14 i1="04"><s1>Department of Neuropathology, Massachusetts General Hospital</s1>
<s2>Boston</s2>
<s3>USA</s3>
<sZ>5 aut.</sZ>
</fA14>
<fA14 i1="05"><s1>Department of Neurology Institute of Psychiatry</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>6 aut.</sZ>
</fA14>
<fA14 i1="06"><s1>Ludwig Boltzmann Institute of Clinical Neurobiology</s1>
<s2>Vienna</s2>
<s3>AUT</s3>
<sZ>7 aut.</sZ>
</fA14>
<fA14 i1="07"><s1>Parkinson's Disease Society Brain Tissue Bank, Institute of Neurology</s1>
<s2>London</s2>
<s3>GBR</s3>
<sZ>8 aut.</sZ>
</fA14>
<fA20><s1>65-74</s1>
</fA20>
<fA21><s1>1997</s1>
</fA21>
<fA23 i1="01"><s0>ENG</s0>
</fA23>
<fA43 i1="01"><s1>INIST</s1>
<s2>998</s2>
<s5>354000063119560060</s5>
</fA43>
<fA44><s0>0000</s0>
<s1>© 1997 INIST-CNRS. All rights reserved.</s1>
</fA44>
<fA45><s0>2 p.</s0>
</fA45>
<fA47 i1="01" i2="1"><s0>97-0171624</s0>
</fA47>
<fA60><s1>P</s1>
</fA60>
<fA61><s0>A</s0>
</fA61>
<fA64 i1="01" i2="1"><s0>Brain</s0>
</fA64>
<fA66 i1="01"><s0>GBR</s0>
</fA66>
<fC01 i1="01" l="ENG"><s0>The difficulty in differentiating progressive supranuclear palsy (PSP, also called Steele-Richardson-Olszewski syndrome) from other related disorders was the incentive for a study to determine the clinical features that best distinguish PSP. Logistic regression and classification and regression tree analysis (CART) were used to analyse data obtained at the first visit from a sample of 83 patients with a clinical history of parkinsonism or dementia confirmed neuropathologically including PSP (n = 24), corticobasal degeneration (n = 11), Parkinson's disease (PD, n = 11), diffuse Lewy body disease (n = 14), Pick's disease (n = 8) and multiple system atrophy (MSA, n = 15). Supranuclear vertical gaze palsy, moderate or severe postural instability and falls during the first year after onset of symptoms classified the sample with 9% error using logistic regression analysis. The CART identified similar features and was also helpful in identifying particular attributes that separate PSP from each of the other disorders. Unstable gait, absence of tremor-dominant disease and absence of response to levodopa differentiated PSP from PD. Supranuclear vertical gaze palsy, gait instability and the absence of delusions distinguished PSP from diffuse Lewy body disease. Supranuclear vertical gaze palsy and increased age at symptom-onset distinguished PSP from MSA. Gait abnormality severe upward gaze palsy, bilateral bradykinesia and absence of alien limb syndrome separated PSP from corticobasal degeneration. Postural instability successfully classified PSP from Pick's disease. The present study may help to minimize the difficulties neurologists experience when attempting to classify these disorders at early stages.</s0>
</fC01>
<fC02 i1="01" i2="X"><s0>002B17G</s0>
</fC02>
<fC03 i1="01" i2="X" l="FRE"><s0>Ophtalmoplégie supranucléaire</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="ENG"><s0>Supranuclear ophthalmoplegia</s0>
<s5>01</s5>
</fC03>
<fC03 i1="01" i2="X" l="SPA"><s0>Oftalmoplejía supranuclear</s0>
<s5>01</s5>
</fC03>
<fC03 i1="02" i2="X" l="FRE"><s0>Progressif</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="ENG"><s0>Progressive</s0>
<s5>02</s5>
</fC03>
<fC03 i1="02" i2="X" l="SPA"><s0>Progresivo</s0>
<s5>02</s5>
</fC03>
<fC03 i1="03" i2="X" l="FRE"><s0>Anatomopathologie</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="ENG"><s0>Pathology</s0>
<s5>04</s5>
</fC03>
<fC03 i1="03" i2="X" l="SPA"><s0>Anatomía patológica</s0>
<s5>04</s5>
</fC03>
<fC03 i1="04" i2="X" l="FRE"><s0>Classification</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="ENG"><s0>Classification</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="GER"><s0>Klassifizierung</s0>
<s5>16</s5>
</fC03>
<fC03 i1="04" i2="X" l="SPA"><s0>Clasificación</s0>
<s5>16</s5>
</fC03>
<fC03 i1="05" i2="X" l="FRE"><s0>Diagnostic différentiel</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="ENG"><s0>Differential diagnostic</s0>
<s5>17</s5>
</fC03>
<fC03 i1="05" i2="X" l="SPA"><s0>Diagnóstico diferencial</s0>
<s5>17</s5>
</fC03>
<fC03 i1="06" i2="X" l="FRE"><s0>Homme</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="ENG"><s0>Human</s0>
<s5>20</s5>
</fC03>
<fC03 i1="06" i2="X" l="SPA"><s0>Hombre</s0>
<s5>20</s5>
</fC03>
<fC03 i1="07" i2="X" l="FRE"><s0>Analyse statistique</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="ENG"><s0>Statistical analysis</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="GER"><s0>Statistische Analyse</s0>
<s5>23</s5>
</fC03>
<fC03 i1="07" i2="X" l="SPA"><s0>Análisis estadístico</s0>
<s5>23</s5>
</fC03>
<fC07 i1="01" i2="X" l="FRE"><s0>Oeil pathologie</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="ENG"><s0>Eye disease</s0>
<s5>37</s5>
</fC07>
<fC07 i1="01" i2="X" l="SPA"><s0>Ojo patología</s0>
<s5>37</s5>
</fC07>
<fC07 i1="02" i2="X" l="FRE"><s0>Oculomotricité syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="ENG"><s0>Oculomotor syndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="02" i2="X" l="SPA"><s0>Oculomotricidad síndrome</s0>
<s5>38</s5>
</fC07>
<fC07 i1="03" i2="X" l="FRE"><s0>Système nerveux pathologie</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="ENG"><s0>Nervous system diseases</s0>
<s5>39</s5>
</fC07>
<fC07 i1="03" i2="X" l="SPA"><s0>Sistema nervioso patología</s0>
<s5>39</s5>
</fC07>
<fC07 i1="04" i2="X" l="FRE"><s0>Système nerveux central pathologie</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="ENG"><s0>Central nervous system disease</s0>
<s5>40</s5>
</fC07>
<fC07 i1="04" i2="X" l="SPA"><s0>Sistema nervosio central patología</s0>
<s5>40</s5>
</fC07>
<fC07 i1="05" i2="X" l="FRE"><s0>Tronc cérébral syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="ENG"><s0>Brain stem syndrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="05" i2="X" l="SPA"><s0>Tallo encefalico sindrome</s0>
<s5>41</s5>
</fC07>
<fC07 i1="06" i2="X" l="FRE"><s0>Encéphale pathologie</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="ENG"><s0>Cerebral disorder</s0>
<s5>42</s5>
</fC07>
<fC07 i1="06" i2="X" l="SPA"><s0>Encéfalo patología</s0>
<s5>42</s5>
</fC07>
<fC07 i1="07" i2="X" l="FRE"><s0>Maladie dégénérative</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="ENG"><s0>Degenerative disease</s0>
<s5>43</s5>
</fC07>
<fC07 i1="07" i2="X" l="SPA"><s0>Enfermedad degenerativa</s0>
<s5>43</s5>
</fC07>
<fN21><s1>083</s1>
</fN21>
</pA>
</standard>
</inist>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PascalFrancis/Curation

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001885 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/PascalFrancis/Curation/biblio.hfd -nk 001885 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PascalFrancis
   |étape=   Curation
   |type=    RBID
   |clé=     Pascal:97-0171624
   |texte=   Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study
}}

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024

	La maladie de Parkinson en France (serveur d'exploration)
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

La maladie de Parkinson en France (serveur d'exploration)

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study

Which clinical features differentiate progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome) from related disorders: A clinicopathological study

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri